Tim Wilsdon and Ryan Lawlor from Charles River Associates explain why price-based procurement strategies can limit the long-term effectiveness and sustainability of vaccine programmes.
Vaccination programmes implemented across Europe and other regions around the world play a central role in the prevention and spread of many serious infectious diseases and have brought significant benefits to both patients and clinicians. These programmes are estimated to save the lives of more than 2.5 million children worldwide each year and are responsible for the eradication of smallpox as well as the elimination of measles, diphtheria and rubella in many regions.1,2 With the ongoing COVID-19 pandemic and the global focus on developing a vaccine, the importance of government-sponsored vaccination programmes is clearer than ever.
This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.
Key learning points:
Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
Learn about ITM’s implementation journey and considerations when evaluating the technology
Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).
Don’t miss your chance to learn from experts in the industry –Register for FREE
Can’t attend live? No worries – register to receive the recording post-event.
There are a variety of models that are used to procure vaccines for large-scale immunisation programmes, governed by the European legal framework for procurement. These range from price-based models, designed to acquire vaccines at the lowest cost possible, to value-based models that focus on a drug’s perceived value to clinicians, patients and healthcare systems. Price-based models are popular in many countries as they result in lower costs in the short term. However, a recent analysis led by the Life Sciences team at Charles River Associates (CRA) indicates that a price-based vaccine procurement model can limit the long-term effectiveness and sustainability of many vaccination programmes and potentially put public health at risk.
Figure 1: Types of procurement mechanisms for vaccines [credit: CRA analysis].
To better understand how vaccine procurement mechanisms can impact the overall sustainability of immunisation programmes and the ability to meet public health goals, the team reviewed programme descriptions and assessments from multiple sources including government websites, databases and peer-reviewed journal publications. This was complemented by interviews with a range of stakeholders in the life sciences sector including government officials, academics, payers and public health specialists. The focus was placed on countries that use a range of procurement mechanisms, from those which primarily focus on price to those that take a more value-based approach (Figure 1). Germany, Italy, Spain and Romania were selected as countries with different mechanisms in place. The relationship was then documented between procurement model dynamics and the level of protection against vaccine preventable diseases: measles, hexavalent and influenza vaccines.
Challenges with price-based procurement
Research shows that the use of price-based models, particularly those involving a ‘winner-takes-all’ approach, will typically result in often significant short-term reductions in vaccine costs. In one example, when Germany first introduced price-based procurement for influenza vaccines in 2011 the price subsequently dropped by about 30 percent in the first year and by about 56 percent the following year (Figure 2). In contrast, prices for vaccines that were not purchased based on a lowest-cost model – including those for hexavalent and measles, mumps and rubella (MMR) – remained consistent during the same period.
Although price-based models can bring short-term financial savings, they may be associated with reduced vaccination coverage rates (VCRs) in Europe. Routine immunisation coverage of the first dose of a measles-containing vaccine has declined in 12 EU states since 2010, accompanied by a resurgence in measles cases during the same period.3,4 In Spain, recent efforts to achieve lower vaccine prices in all regions, following a national framework agreement implemented in 2011, have correlated with a decline in influenza VCRs (Figure 3). While this did result in a 37 percent price reduction, there was also evidence of a 14 percent fall in VCR. Similarly, analysis of trends in both the Puglia region of Italy and Romania found a decline in VCRs during a period when vaccine prices also were reduced. Overall, evidence shows that lower prices have not been able to maintain or increase VCR across countries.
Figure 3: Influenza vaccine price and vaccine coverage rate in Spain (2005–2017) [credit: Ministry of Health, Social Services and Equality].
Price-based models have also been found to exacerbate supply issues. For example, since Spain began purchasing vaccines based on price, the country has seen difficulty identifying suppliers – particularly for diphtheria, MMR, tetanus, pertussis, pneumococcus, typhoid fever, rabies and yellow fever vaccines, due to the lower commercial attractiveness of the terms.5 In response, government officials increased the MMR vaccine price in 2014 to incentivise manufacturers to continue supplying the Spanish market.6 When manufacturers find a market less attractive and decline to participate, this can increase the potential for supply interruptions and reduced competition. In the long term, the impact on market competition and manufacturers’ willingness to invest in R&D could stagnate innovation, leading to areas of unmet need.
…price-based vaccine procurement model can limit the long-term effectiveness and sustainability of many vaccination programmes”
The complex and lengthy production process required for vaccines, including many that are combination therapies, is also an important consideration that can potentially affect supply. In 2012, Germany awarded a sole supplier the responsibility of producing influenza vaccines for several states. When the supplier was unable to deliver the one million doses it promised due to identified impurities, their exclusive contract meant that there were no other influenza vaccine suppliers with available stock.7 Manufacturers often cannot rapidly increase production or reallocate vaccine doses even if they are positioned as ‘back-up’ suppliers because of late demand and necessary production timelines. Poor planning of local supply needs and manufacturing timeframes can lead to vaccine shortages and failure to dose populations within appropriate immunisation windows, potentially putting thousands of people at risk of developing otherwise preventable diseases.
Innovative strategies in vaccine procurement
As governments throughout Europe recognise the potential long-term risks associated with price-based models, many are considering new and innovative procurement strategies. Some plans being put into place now allow for multiple suppliers, shorter contracts and delivery timelines that take into account complex and lengthy production timelines. In Romania, a recent shortage of MMR vaccines led the government to recruit additional suppliers outside the country. In 2017, the government also amended its vaccine procurement policies to consider value criteria including the pre-determined quality of vaccines in addition to price.8 Government officials in Italy and Spain are taking steps to encourage manufacturers to stay in their markets to have access to multiple suppliers and facilitate long-term competition.9
Some countries are also transitioning to procurement mechanisms that prioritise value-added services in an effort to increase or maintain VCRs. The Spanish and Italian governments are increasingly realising that anti-vaccination campaigns and a lack of awareness and understanding of vaccine public health benefits are significantly impacting VCRs. As a result, some regions are requiring vaccine purchasing agreements to include value-based services to increase the availability of educational resources for clinicians and patients.
Strategies moving forward
Based on these analyses, there is compelling evidence indicating that procurement strategies based solely or primarily on price can put the future sustainability of global vaccination programmes at risk. These strategies are shown to increase the risk of supply shortages and limit public understanding of the health benefits of vaccines. Furthermore, the addition of value-added services such as training programmes for healthcare professionals, public awareness campaigns, better patient monitoring and vaccines registries can play an important role in improving outcomes and supporting long-term sustainability.
…some regions are requiring vaccine purchasing agreements to include value-based services”
The need for more innovation in vaccine procurement strategies is also driven by recent recommendations from the EU Council calling for countries to strengthen cross-border co-operation in the fight against vaccine-preventable diseases. These recommendations encourage EU member states and the European Commission (EC) to develop joint actions aimed at sharing best practices on vaccination policies.10 It will be important for manufacturers and purchasers to communicate openly and collaborate to address challenges together. Consistent engagement will allow both parties to align on solutions that can help ensure the long-term sustainability of vaccination programmes and improve the health and quality of life of many people around the world in the years ahead.
About the authors
Tim Wilsdon is a Vice President in the Life Sciences Practice at CRA. Wilsdon leads the global public policy sector and has undertaken many studies for the EC, industry trade associations (EFPIA, PhRMA and IFPMA) and many innovative companies.
Ryan Lawlor is a Senior Associate in CRA’s Life Sciences Practice. He delivers and manages CRA’s European health policy projects, advising life sciences clients on health financing, pricing and reimbursement and policy environment shaping.
The authors wish to acknowledge the contributions of Alexandru Rafila, Carol Davila University of Medicine and Pharmacy; Amós García Rojas, Epidemiology and Prevention Servicio Canario de la Salud to this article. Funding for this project came from Sanofi Pasteur.
The views expressed herein are the authors’ and not those of Charles River Associates (CRA) or any of the organisations with which the authors are affiliated.
References
A. Orenstein, R. Ahmed. Simply put: Vaccination saves lives. PNAS. 2017 Apr 18; 114 (16): 4031-4033. Available from: http://www.pnas.org/content/114/16/4031
International Federation of Pharmaceutical Manufacturers & Associations. The Pharmaceutical Industry and Global Health. Facts and Figures 2017 [Internet]. International Federation of Pharmaceutical Manufacturers & Associations; 2017 [cited 2017 Sept 12]. Available from: https://www.ifpma.org/wp-content/uploads/2017/02/IFPMA-Facts-And-Figures-2017.pdf
Larson, A. de Figueiredo, E. Karafillakis, M. Rawal. State of vaccine confidence in the EU 2018 [Internet]. Luxembourg: Publications Office of the European Union; 2018 [cited 2019 Sept 18]. Available from: https://ec.europa.eu/health/sites/health/files/vaccination/docs/2018_vaccine_confidence_en. pdf DOI: 10.2875/241099
M. Danzon, N. S. Pereira. Vaccine Supply: Effects Of Regulation And Competition. Int J Econ Bus. 2011 July; 18(2): 239-271. Available from: http://www.nber.org/papers/w17205 DOI: 10.3386/w17205 DOI: 10.3386/w17205
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.
What a fun read – I’ll be sharing with my husband. This is appreciated!